Add to Cart View Cart/Checkout More Products

Volume 17, 2013 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2013 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 17 No. 1 January/February 2013 Volume 17, Number 1
Vol. 17 No. 2 March/April 2013 Volume 17, Number 2
Vol. 17 No. 3 May/June 2013 Volume 17, Number 3
Vol. 17 No. 4 July/August 2013 Volume 17, Number 4
Vol. 17 No. 5 September/October 2013 Volume 17, Number 5
Vol. 17 No. 6 November/December 2013 Volume 17, Number 6

Articles
Volume/IssuePageTitle
Vol. 17 No. 1 4 PreScription: How Many Pharmacies Compound and What Do They Compound?
Vol. 17 No. 1 4 PreScription: Looking for Solutions
Vol. 17 No. 1 6 Pediatric Health Care: An Introduction
Vol. 17 No. 1 10 Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Vol. 17 No. 1 24 Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Vol. 17 No. 1 28 Treatment Options for Male Hypogonadism
Vol. 17 No. 1 39 Adrenal Fatigue
Vol. 17 No. 1 48 International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives
Vol. 17 No. 1 50 Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves
Vol. 17 No. 1 54 Basics of Compounding: Repackaging, Part 1
Vol. 17 No. 1 62 Calculations
Vol. 17 No. 1 64 Desmopressin 4-mcg/mL Injection
Vol. 17 No. 1 65 Dobutamine 10-mg/mL Injection
Vol. 17 No. 1 66 Granisetron 1-mg/mL Injection
Vol. 17 No. 1 67 Ibuprofen 10-mg/mL Injection
Vol. 17 No. 1 68 Mepivacaine Hydrochloride 1% Injection
Vol. 17 No. 1 69 Milrinone 0.2-mg/mL Injection
Vol. 17 No. 1 70 Neostigmine Methylsulfate 0.5-mg/mL Injection
Vol. 17 No. 1 71 Nicardipine Hydrochloride Injection
Vol. 17 No. 1 72 Octreotide 50-mcg/mL Injection
Vol. 17 No. 1 73 Testosterone Cypionate 100-mg/mL Injection
Vol. 17 No. 1 74 The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Vol. 17 No. 1 86 Errata
Vol. 17 No. 1 87 PostScription: GMPs and GCPs: A Topical Comparison
Vol. 17 No. 2 92 PreScription: Pharmacy Committees
Vol. 17 No. 2 94 Sterilization of Compounded Parenteral Products: Verification of Autoclaves
Vol. 17 No. 2 100 Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Vol. 17 No. 2 113 Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Vol. 17 No. 2 124 Compounding in Ukraine
Vol. 17 No. 2 128 International Academy of Compounding Pharmacists Legislative/Regulatory Update
Vol. 17 No. 2 130 Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Vol. 17 No. 2 136 Basics of Compounding: Repackaging, Part 2
Vol. 17 No. 2 142 Calculations
Vol. 17 No. 2 144 Adenosine 3-mg/mL Injection
Vol. 17 No. 2 145 Alcohol Dehydrated Injection
Vol. 17 No. 2 146 Betahistine 16-mg Capsules
Vol. 17 No. 2 147 Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Vol. 17 No. 2 148 Cyanocobalamin 1000-mcg/mL Injection
Vol. 17 No. 2 149 Dexrazoxane 1-mg/mL Injection
Vol. 17 No. 2 150 Meropenem 50-mg/mL Injection
Vol. 17 No. 2 151 Paclitaxel 6-mg/mL Injection
Vol. 17 No. 2 152 Thiotepa 15-mg/mL Injection
Vol. 17 No. 2 153 Verapamil Hydrochloride 2.5-mg/mL Injection
Vol. 17 No. 2 154 Compounding Practices and Beliefs of Arizona Pharmacists
Vol. 17 No. 2 162 Stability of Rifampin in SyrSpend SF
Vol. 17 No. 2 165 Stability of Minoxidil in Espumil Foam Base
Vol. 17 No. 2 168 Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Vol. 17 No. 3 180 PreScription: Compounding for Drug Shortages
Vol. 17 No. 3 182 Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Vol. 17 No. 3 193 Decontamination Technology: The Missing Element
Vol. 17 No. 3 201 Optimizing Third-party Reimbursement for Compounded Medications
Vol. 17 No. 3 206 International Academy of Compounding Pharmacists' Legislative/Regulatory Update
Vol. 17 No. 3 210 Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Vol. 17 No. 3 220 Basics of Compounding: Potency and Stability Testing
Vol. 17 No. 3 226 Calculations
Vol. 17 No. 3 228 Buffered Aspirin Capsules
Vol. 17 No. 3 229 Calcium Acetate 667-mg Capsules
Vol. 17 No. 3 230 Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Vol. 17 No. 3 231 Ethambutol 400-mg Capsules
Vol. 17 No. 3 232 Isoniazid 300-mg Capsules
Vol. 17 No. 3 233 Labetalol 50-mg Capsules
Vol. 17 No. 3 234 Mercaptopurine 75-mg Capsules
Vol. 17 No. 3 235 Naltrexone Hydrochloride 50-mg Capsules
Vol. 17 No. 3 236 Prednisone 10-mg Capsules
Vol. 17 No. 3 237 Reserpine 0.5-mg Capsules
Vol. 17 No. 3 238 Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Vol. 17 No. 3 247 Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Vol. 17 No. 3 254 Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Vol. 17 No. 3 262 PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Vol. 17 No. 4 268 Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update
Vol. 17 No. 4 270 Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Vol. 17 No. 4 283 United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Vol. 17 No. 4 290 Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover
Vol. 17 No. 4 294 Types of Pharmacy/Pharmacists
Vol. 17 No. 4 302 International Academy of Compounding Pharmacists Legislative/Regulatory Update
Vol. 17 No. 4 307 Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Vol. 17 No. 4 312 Basics of Compounding: Foam Dosage Forms
Vol. 17 No. 4 324 Calculations
Vol. 17 No. 4 326 Acyclovir 20-mg/mL Oral Suspension
Vol. 17 No. 4 327 Acyclovir 200-mg Capsules
Vol. 17 No. 4 328 Allopurinol Sodium 4-mg/mL Injection
Vol. 17 No. 4 329 Amikacin Sulfate 250-mg/mL Injection
Vol. 17 No. 4 330 Dacarbazine 200-mg/mL Injection
Vol. 17 No. 4 331 Ketamine 50-mg/mL Injection
Vol. 17 No. 4 332 Methohexital Sodium 500-mg/mL Injection
Vol. 17 No. 4 333 Metoprolol Tartrate 1-mg/mL Injection
Vol. 17 No. 4 334 Rifampin 300-mg and Isoniazid 150-mg Capsules
Vol. 17 No. 4 335 Succinylcholine Chloride 50-mg/mL Injection
Vol. 17 No. 4 336 Stability of Captopril in SyrSPend SF
Vol. 17 No. 4 339 Patient-centered Care as Value-added Service by Compounding Pharmacists
Vol. 17 No. 4 344 Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Vol. 17 No. 4 347 Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs
Vol. 17 No. 4 351 PostScription: Traditional vs Nontraditional Pharmacy
Vol. 17 No. 5 356 PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Vol. 17 No. 5 358 Compounding Pharmacies: Before and After an Inspection
Vol. 17 No. 5 364 Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
Vol. 17 No. 5 370 Chemical Penetration Enhancers
Vol. 17 No. 5 375 2013 State Compounding Legislation Tracker Updated: August 12, 2013
Vol. 17 No. 5 380 Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Vol. 17 No. 5 384 Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Vol. 17 No. 5 388 Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Vol. 17 No. 5 393 Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach
Vol. 17 No. 5 400 Basics of Compounding: Basics of Compounding with Tars
Vol. 17 No. 5 412 Calculations
Vol. 17 No. 5 414 Acyclovir 50-mg/mL Injection
Vol. 17 No. 5 415 Aminocaproic Acid 250-mg/mL Injection
Vol. 17 No. 5 416 Clindamycin 150-mg/mL Injection
Vol. 17 No. 5 417 Fluorouracil 50-mg/mL Injection
Vol. 17 No. 5 418 Hydroxyzine Hydrochloride 25-mg/mL Injection
Vol. 17 No. 5 419 Indomethacin 1-mg/mL Injection
Vol. 17 No. 5 420 Mesna 100-mg/mL Injection
Vol. 17 No. 5 421 Methotrexate 25-mg/mL Injection
Vol. 17 No. 5 422 Phenylephrine Hydrochloride 10-mg/mL Injection
Vol. 17 No. 5 423 Terbutaline Sulfate 1-mg/mL Injection
Vol. 17 No. 5 424 In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Vol. 17 No. 5 432 Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Vol. 17 No. 5 436 Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration
Vol. 17 No. 5 439 PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Vol. 17 No. 6 444 PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding
Vol. 17 No. 6 446 Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Vol. 17 No. 6 452 Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Vol. 17 No. 6 459 Considerations for Pharmacists Working in Major Disaster Areas
Vol. 17 No. 6 465 Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Vol. 17 No. 6 477 Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Vol. 17 No. 6 480 HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?
Vol. 17 No. 6 482 Marketing During the Holidays
Vol. 17 No. 6 485 Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Vol. 17 No. 6 490 Basics of Compounding: Basics of Compounding with Balsams
Vol. 17 No. 6 496 Calculations
Vol. 17 No. 6 498 Benztropine Mesylate 1-mg/mL Injection
Vol. 17 No. 6 499 Cefazolin 250-mg/mL Injection
Vol. 17 No. 6 500 Ciprofloxacin 250-mg Capsules
Vol. 17 No. 6 501 Cortisone Acetate 25-mg Capsules
Vol. 17 No. 6 502 Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Vol. 17 No. 6 503 Dihydroergotamine Mesylate 1-mg/mL Injection
Vol. 17 No. 6 504 Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Vol. 17 No. 6 505 Levothyroxine Sodium 100-mcg Capsules
Vol. 17 No. 6 506 Metyrosine 250-mg Capsules
Vol. 17 No. 6 507 Phenytoin Sodium 50-mg/mL Injection
Vol. 17 No. 6 508 Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
Vol. 17 No. 6 512 Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Vol. 17 No. 6 515 Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes
Vol. 17 No. 6 520 Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Vol. 17 No. 6 526 PostScription: Augmented Reality for Readers and Authors